ClearPoint Neuro, Inc. Basic Shares Outstanding (Weighted Average)
ClearPoint Neuro, Inc. (CLPT) reported Basic Shares Outstanding (Weighted Average) of 30.17 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-03
- ClearPoint Neuro, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 30.17M shares, a 6.75% increase year-over-year.
- ClearPoint Neuro, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 29.55M shares, a 6.59% increase year-over-year.
- ClearPoint Neuro, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 28.85M shares, a 4.56% increase year-over-year.
- ClearPoint Neuro, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 28.43M shares, a 3.03% increase year-over-year.
- ClearPoint Neuro, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 28.32M shares, a 4.76% increase from fiscal 2024.
- ClearPoint Neuro, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 27.03M shares, a 9.85% increase from fiscal 2023.
- ClearPoint Neuro, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 24.61M shares, a 1.75% increase from fiscal 2022.
- ClearPoint Neuro, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 24.18M shares, a 16.63% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 30.17M shares 10-Q · filed 2026-08-03 | 29.86M shares 10-Q · filed 2026-08-03 | 29.52M shares derived: average of 3 quarters · filed 2026-08-03 | 29.25M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 29.55M shares 10-Q · filed 2026-05-13 | 29.20M shares derived: average of 2 quarters · filed 2026-05-13 | 28.94M shares derived: average of 3 quarters · filed 2026-05-13 | 28.77M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | 28.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 28.64M shares derived: average of 2 quarters · filed 2026-03-17 | 28.51M shares derived: average of 3 quarters · filed 2026-08-03 | 28.32M shares 10-K · filed 2026-03-17 |
| 2025-09-30 | 28.43M shares 10-Q · filed 2025-11-06 | 28.34M shares derived: average of 2 quarters · filed 2026-08-03 | 28.14M shares 10-Q · filed 2025-11-06 | 28.00M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | 28.26M shares 10-Q · filed 2026-08-03 | 27.99M shares 10-Q · filed 2026-08-03 | 27.86M shares derived: average of 3 quarters · filed 2026-08-03 | 27.79M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | 27.72M shares 10-Q · filed 2026-05-13 | 27.65M shares derived: average of 2 quarters · filed 2026-05-13 | 27.63M shares derived: average of 3 quarters · filed 2026-05-13 | 27.59M shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 27.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 27.59M shares derived: average of 2 quarters · filed 2026-03-17 | 27.55M shares derived: average of 3 quarters · filed 2026-03-17 | 27.03M shares 10-K · filed 2026-03-17 |
| 2024-09-30 | 27.59M shares 10-Q · filed 2025-11-06 | 27.53M shares derived: average of 2 quarters · filed 2025-11-06 | 26.84M shares 10-Q · filed 2025-11-06 | 26.28M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | 27.47M shares 10-Q · filed 2025-08-12 | 26.46M shares 10-Q · filed 2025-08-12 | 25.85M shares derived: average of 3 quarters · filed 2025-08-12 | 25.54M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 25.45M shares 10-Q · filed 2025-05-13 | 25.04M shares derived: average of 2 quarters · filed 2025-05-13 | 24.90M shares derived: average of 3 quarters · filed 2025-05-13 | 24.82M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 24.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 24.63M shares derived: average of 2 quarters · filed 2025-02-26 | 24.61M shares derived: average of 3 quarters · filed 2025-02-26 | 24.61M shares 10-K · filed 2025-02-26 |
| 2023-09-30 | 24.63M shares 10-Q · filed 2024-11-07 | 24.61M shares derived: average of 2 quarters · filed 2024-11-07 | 24.60M shares 10-Q · filed 2024-11-07 | 24.59M shares derived: average of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | 24.58M shares 10-Q · filed 2024-08-07 | 24.58M shares 10-Q · filed 2024-08-07 | 24.57M shares derived: average of 3 quarters · filed 2024-08-07 | 24.55M shares derived: average of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | 24.58M shares 10-Q · filed 2024-05-07 | 24.57M shares derived: average of 2 quarters · filed 2024-05-07 | 24.54M shares derived: average of 3 quarters · filed 2024-05-07 | 24.40M shares derived: average of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | 24.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 24.53M shares derived: average of 2 quarters · filed 2024-03-12 | 24.35M shares derived: average of 3 quarters · filed 2024-03-12 | 24.18M shares 10-K · filed 2024-03-12 |
| 2022-09-30 | 24.50M shares 10-Q · filed 2023-11-09 | 24.24M shares derived: average of 2 quarters · filed 2023-11-09 | 24.06M shares 10-Q · filed 2023-11-09 | 23.37M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 23.99M shares 10-Q · filed 2023-08-08 | 23.83M shares 10-Q · filed 2023-08-08 | 22.99M shares derived: average of 3 quarters · filed 2023-08-08 | 22.87M shares derived: average of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | 23.68M shares 10-Q · filed 2023-05-11 | 22.49M shares derived: average of 2 quarters · filed 2023-05-11 | 22.50M shares derived: average of 3 quarters · filed 2023-05-11 | 22.26M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 21.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 21.91M shares derived: average of 2 quarters · filed 2023-03-01 | 21.78M shares derived: average of 3 quarters · filed 2023-03-01 | 20.73M shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 22.52M shares 10-Q · filed 2022-11-08 | 22.02M shares derived: average of 2 quarters · filed 2022-11-08 | 20.55M shares 10-Q · filed 2022-11-08 | |
| 2021-06-30 | 21.52M shares 10-Q · filed 2022-08-10 | 20.20M shares 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | 18.85M shares 10-Q · filed 2022-05-11 | |||
| 2015-06-30 | 74.84M shares 10-Q · filed 2015-08-10 | 59.24M shares 10-Q · filed 2015-08-10 | ||
| 2015-03-31 | 74.84M shares 10-Q · filed 2015-05-07 | |||
| 2014-06-30 | 58.92M shares 10-Q · filed 2015-08-10 | 58.82M shares 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | 58.72M shares 10-Q · filed 2015-05-07 | |||
| 2013-06-30 | 57.38M shares 10-Q · filed 2014-08-11 | 56.13M shares 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | 54.86M shares 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |